首页 > 市场调查报告书 > 医疗设备

眼科设备

人工角膜和角膜植入市场规模、份额和成长分析（按类型、植入物类型、疾病适应症、最终用户和地区划分）—产业预测，2026-2033年

市场调查报告书

商品编码

1896046

人工角膜和角膜植入市场规模、份额和成长分析（按类型、植入物类型、疾病适应症、最终用户和地区划分）—产业预测，2026-2033年

Artificial Cornea and Corneal Implant Market Size, Share, and Growth Analysis, By Type (Human Cornea, Artificial Cornea), By Transplant Type, By Disease Indication, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月15日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球人工角膜和角膜植入市场规模预计在 2024 年达到 4.8781 亿美元，从 2025 年的 5.2391 亿美元增长到 2033 年的 9.2745 亿美元，在预测期（2026-2033 年）内复合年增长率为 7.4%。

市场分析表明，眼疾发病率的上升以及消费者对眼科保健投入意愿的增强，预计将推动人工角膜和角膜植入的需求成长。此外，人们对眼角膜捐赠意识的提高以及器官捐赠者数量的增加也是促进市场成长的因素。可靠的眼移植手术的日益普及以及相关医疗报销的改善，进一步支撑了人工角膜和角膜植入的销售增长。然而，某些地区的高成本可能会限制市场发展。此外，全球人口老化的快速成长将持续推动对人工角膜和角膜植入的需求，使其成为不断发展的眼科保健领域的重要组成部分。

推动全球人工角膜和角膜植入市场发展的因素

全球人口老化以及萤幕使用时间的增加，显着加剧了角膜疾病的盛行率。眼部疾病的激增推动了角膜移植作为治疗选择的需求成长。因此，人工角膜和角膜植入的需求预计将会成长，这反映出眼科领域对创新解决方案的迫切需求。随着越来越多的患者面临角膜健康问题，人工角膜和植入市场有望从中受益，使其成为应对不断变化的人口健康需求的关键解决方案。

限制全球人工角膜和角膜植入市场发展的因素

全球人工角膜和角膜植入市场面临许多挑战，主要原因是各种医疗保险计划对角膜移植手术的覆盖范围和报销额度有限。因此，许多患者不得不自费承担这些费用。高昂的手术费用可能会阻碍患者进行如此大额的投资，从而抑制市场的整体成长和扩张。由此，患者面临的经济负担成为一大阻碍因素，限制了他们获得必要的治疗，并阻碍了创新型角膜解决方案的研发。

全球人工角膜和角膜植入市场趋势

全球人工角膜和角膜植入市场正呈现出微创手术技术日益普及的显着趋势。随着患者偏好转向这些创伤较小的治疗方案，製造商正致力于提升此类手术产品的可及性和有效性。同时，为这些先进疗法争取有利的报销机制预计将进一步推动市场需求和扩张。这种不断变化的市场格局不仅凸显了创新解决方案的重要性，也强烈提醒市场相关人员，必须适应眼科护理领域消费者不断变化的需求。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

CorNeat Vision（Israel）
KeraMed, Inc.（USA）
LinkoCare Life Sciences AB（Sweden）
DIOPTEX GmbH（Austria）
EyeYon Medical（Israel）
AJL Ophthalmic SA（Spain）
Mediphacos（Brazil）
CorneaGen（USA）
Florida Lions Eye Bank（USA）
San Diego Eye Bank（USA）
Alabama Eye Bank（USA）
Massachusetts Eye and Ear（USA）
Advancing Sight Network（USA）
LV Prasad Eye Institute（LVPEI, India）
Alcon Inc.（Switzerland）
Aurolab（India）
Cornea Biosciences（USA）
Price Vision Group（USA）

结论与建议

简介目录

Product Code: SQMIG35B2204

Global Artificial Cornea and Corneal Implant Market size was valued at USD 487.81 Million in 2024 and is poised to grow from USD 523.91 Million in 2025 to USD 927.45 Million by 2033, growing at a CAGR of 7.4% during the forecast period (2026-2033).

Market insights reveal that the rising incidence of ophthalmic diseases, combined with consumers' increased willingness to invest in eye care, is expected to enhance demand for artificial corneas and corneal implants. Additionally, heightened awareness about eye donation and a growing number of organ donors are contributing factors to the expansion of this market. The growing accessibility of reliable eye transplant procedures and improvements in reimbursement for these procedures further support the anticipated sales growth of artificial corneas and corneal implants. Nonetheless, high costs in certain regions may impede market development. Furthermore, the rapidly increasing geriatric population globally is likely to drive sustained demand for artificial corneas and corneal implants, positioning them as critical components in the evolving eye care landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Artificial Cornea and Corneal Implant market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Artificial Cornea and Corneal Implant Market Segments Analysis

Global Artificial Cornea and Corneal Implant Market is segmented by Type, Transplant Type, Disease Indication, End User and region. Based on Type, the market is segmented into Human Cornea and Artificial Cornea. Based on Transplant Type, the market is segmented into Penetrating Keratoplasty, Endothelial Keratoplasty, Anterior lamellar keratoplasty and keratoprosthesis. Based on Disease Indication, the market is segmented into Fuchs' Dystrophy, Fungal Keratitis, Keratoconus and Others. Based on End User, the market is segmented into Hospitals & Ambulatory Surgical Centers and Specialty Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Artificial Cornea and Corneal Implant Market

The rising global aging population, coupled with heightened exposure to screens, has significantly contributed to the prevalence of corneal disorders. This surge in eye-related issues is driving an increasing demand for corneal transplantation as a treatment option. As a result, the need for artificial corneas and corneal implants is expected to grow, reflecting the urgent requirement for innovative solutions in eye care. With more individuals facing corneal health challenges, the market for artificial corneas and implants stands to benefit, showcasing a critical response to the health needs of an evolving demographic landscape.

Restraints in the Global Artificial Cornea and Corneal Implant Market

The Global Artificial Cornea and Corneal Implant market faces challenges due to limited coverage and reimbursement for corneal transplantation procedures by various healthcare insurance plans. As a result, many individuals must finance these services out of their own pockets. The high costs associated with these procedures contribute to patients' reluctance to invest significant amounts of money, which may hinder the overall growth and expansion of the market. Consequently, the financial burden placed on patients can act as a significant restraint, limiting access to essential treatments and impeding the advancement of innovative corneal solutions.

Market Trends of the Global Artificial Cornea and Corneal Implant Market

The global market for artificial corneas and corneal implants is witnessing a significant trend towards the adoption of minimally invasive surgical techniques. As patient preferences shift towards these less invasive options, manufacturers are encouraged to enhance the accessibility and efficacy of their products tailored for such procedures. Concurrently, a focus on securing favorable reimbursement frameworks for these advanced treatments is expected to further stimulate demand and expansion within the market. This evolving landscape not only highlights the importance of innovative solutions but also underscores the necessity for market players to adapt to evolving consumer expectations in ocular health.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Artificial Cornea and Corneal Implant Market Size by Type & CAGR (2026-2033)

Market Overview
Human Cornea
Artificial Cornea

Global Artificial Cornea and Corneal Implant Market Size by Transplant Type & CAGR (2026-2033)

Market Overview
Penetrating Keratoplasty
Endothelial Keratoplasty
Anterior lamellar keratoplasty
keratoprosthesis

Global Artificial Cornea and Corneal Implant Market Size by Disease Indication & CAGR (2026-2033)

Market Overview
Fuchs' Dystrophy
Fungal Keratitis
Keratoconus
Others

Global Artificial Cornea and Corneal Implant Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals & Ambulatory Surgical Centers
Specialty Clinics

Global Artificial Cornea and Corneal Implant Market Size & CAGR (2026-2033)

North America (Type, Transplant Type, Disease Indication, End User)
- US
- Canada
Europe (Type, Transplant Type, Disease Indication, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Transplant Type, Disease Indication, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Transplant Type, Disease Indication, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Transplant Type, Disease Indication, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

CorNeat Vision (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
KeraMed, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LinkoCare Life Sciences AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DIOPTEX GmbH (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EyeYon Medical (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AJL Ophthalmic SA (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mediphacos (Brazil)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CorneaGen (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Florida Lions Eye Bank (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
San Diego Eye Bank (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alabama Eye Bank (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Massachusetts Eye and Ear (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Advancing Sight Network (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
L V Prasad Eye Institute (LVPEI, India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alcon Inc. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aurolab (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cornea Biosciences (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Price Vision Group (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments